BGI Americas

BGI currently serves customers in over 66 countries, providing integrated genomic sequencing and proteomics services and solutions to academic institutions, pharmaceutical companies, healthcare providers, and other organizations, covering a wide range of applications: fundamental research on humans, plants, animals, and microbial species; clinical research on human health; drug discovery and development; agriculture, biodiversity conservation, and sustainability. With nearly 20 years of genomics experience, we deliver rapid, high-quality results by utilizing a series of cost-effective, cutting-edge technologies (including our own innovative DNBseq™ sequencing technology) to help customers achieve their research goals.